Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19.
Ontology highlight
SUBMITTER: Alape-Giron A
PROVIDER: S-EPMC8450768 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA